Release Date: 22/09/14 09:29 Summary: Change in substantial holding from MTE Price Sensitive: No Download Document 197.29KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%